HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luis Miguel Garcia-Segura Selected Research

tibolone

1/2019Tibolone attenuates inflammatory response by palmitic acid and preserves mitochondrial membrane potential in astrocytic cells through estrogen receptor beta.
7/2018Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta.
5/2018Tibolone Preserves Mitochondrial Functionality and Cell Morphology in Astrocytic Cells Treated with Palmitic Acid.
1/2016Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression.
10/2014Tibolone protects T98G cells from glucose deprivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luis Miguel Garcia-Segura Research Topics

Disease

7Gliosis
01/2019 - 11/2007
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 02/2008
5Inflammation (Inflammations)
01/2019 - 11/2007
5Brain Injuries (Brain Injury)
01/2016 - 11/2007
4Diabetic Neuropathies (Diabetic Neuropathy)
01/2018 - 03/2008
3Obesity
01/2020 - 05/2018
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2019 - 01/2014
3Neuroblastoma
01/2016 - 06/2006
3Peripheral Nervous System Diseases (PNS Diseases)
11/2015 - 01/2011
3Ischemia
11/2014 - 08/2006
3Encephalitis (Encephalitis, Rasmussen)
10/2012 - 11/2007
2Lordosis
01/2021 - 01/2008
2Neoplasms (Cancer)
10/2020 - 02/2008
2Nervous System Diseases (Neurological Disorders)
01/2020 - 01/2016
2Cognitive Dysfunction
01/2020 - 01/2020
2Alopecia (Baldness)
01/2019 - 01/2016
2Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 01/2017
2hypoglycemic encephalopathy
01/2017 - 01/2010
2Osteoporosis
01/2016 - 10/2014
2Hypertensive Encephalopathy
02/2015 - 12/2010
2Pain (Aches)
11/2014 - 04/2014
2Brain Ischemia (Cerebral Ischemia)
11/2014 - 08/2006
2Hyperalgesia
11/2014 - 04/2014
2Infections
10/2014 - 10/2012
2Metabolic Bone Diseases (Osteopenia)
01/2010 - 01/2010
1Overweight
01/2020
1Neuroinflammatory Diseases
01/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Bacterial Infections (Bacterial Infection)
01/2017
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2016
1Essential Hypertension
02/2015
1Brain Diseases (Brain Disorder)
02/2015
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2015
1Stroke (Strokes)
11/2014
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2014
1Neuralgia (Stump Neuralgia)
04/2014
1Penetrating Head Injuries (Penetrating Head Injury)
01/2014
1Stab Wounds (Stab Wound)
01/2014

Drug/Important Bio-Agent (IBA)

9NeurosteroidsIBA
01/2019 - 03/2008
7Estradiol (Delestrogen)FDA LinkGeneric
01/2021 - 08/2006
6Estrogens (Estrogen)FDA Link
01/2019 - 02/2008
6SteroidsIBA
05/2018 - 12/2010
6Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2007
5EnzymesIBA
01/2020 - 11/2014
5tiboloneIBA
01/2019 - 10/2014
4Estrogen Receptor alphaIBA
01/2021 - 06/2006
4Neuroprotective AgentsIBA
01/2016 - 01/2014
4Estrogen ReceptorsIBA
01/2016 - 02/2008
3Palmitic Acid (Hexadecanoic Acid)IBA
01/2019 - 05/2018
3Estrogen Receptor betaIBA
07/2018 - 01/2008
3CholesterolIBA
01/2018 - 11/2014
3Streptozocin (Streptozotocin)FDA Link
01/2018 - 04/2011
3Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2015 - 12/2010
3Messenger RNA (mRNA)IBA
02/2015 - 12/2010
3Protective AgentsIBA
01/2015 - 04/2011
3Selective Estrogen Receptor Modulators (SERM)IBA
10/2014 - 01/2012
2Hormones (Hormone)IBA
10/2020 - 06/2010
2Gonadal HormonesIBA
01/2020 - 04/2011
2Finasteride (Propecia)FDA LinkGeneric
01/2019 - 01/2016
2LipopolysaccharidesIBA
01/2017 - 11/2007
2Aromatase (CYP19)IBA
02/2015 - 11/2014
2Dihydrotestosterone (Androstanolone)IBA
01/2015 - 04/2014
2Testosterone (Sustanon)FDA Link
01/2015 - 04/2014
2Aromatase InhibitorsIBA
11/2014 - 01/2010
2TamoxifenFDA LinkGeneric
01/2014 - 01/2012
2Raloxifene Hydrochloride (Evista)FDA Link
01/2014 - 01/2012
2exemestane (Aromasin)FDA Link
01/2010 - 01/2010
1Arginine Vasopressin (Argipressin)IBA
01/2021
1GTP-Binding Proteins (G-Protein)IBA
01/2021
1Nonesterified Fatty Acids (NEFA)IBA
01/2020
1SuspensionsIBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
05/2018
1CytokinesIBA
01/2017
1CB2 Cannabinoid ReceptorIBA
05/2016
1LeptinIBA
05/2016
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1NeuroglobinIBA
01/2016
1Dehydroepiandrosterone (DHEA)IBA
01/2016
1Glial Fibrillary Acidic ProteinIBA
01/2015
1Letrozole (Femara)FDA LinkGeneric
11/2014
1salicylhydroxamic acid (SHAM)IBA
11/2014
1AndrogensIBA
11/2014
1N-Methylaspartate (NMDA)IBA
11/2014
1Atorvastatin (Lipitor)FDA Link
11/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2014
1ChemokinesIBA
10/2014
1Pharmaceutical PreparationsIBA
10/2014
1LipidsIBA
09/2014
120-alpha-Dihydroprogesterone (20 alpha-Dihydroprogesterone)IBA
09/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2014
1Toll-Like Receptor 4IBA
04/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
04/2014
1Substance PIBA
04/2014
1Analgesics (Analgesic Drugs)IBA
04/2014
1Glutamic Acid (Glutamate)FDA Link
04/2014

Therapy/Procedure

5Therapeutics
01/2020 - 01/2010
2Ovariectomy (Oophorectomy)
01/2014 - 04/2011
1Drug Therapy (Chemotherapy)
11/2015